Inventor
BOSSARD MARY J
US40 patents
⚠️ This page may combine multiple inventors who share the name “BOSSARD MARY J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOSSARD MARY J
17 patentsUS8293869B2Oct 23, 2012
Polymer conjugates of GLP-1
BOSSARD MARY J60 citations97
US9861705B2Jan 9, 2018
Conjugates of an IL-2 moiety and a polymer
BOSSARD MARY J49 citations96
US8507653B2Aug 13, 2013
Factor IX moiety-polymer conjugates having a releasable linkage
BOSSARD MARY J40 citations93
US8580919B2Nov 12, 2013
Polymer conjugates of GLP-1
BOSSARD MARY J16 citations92
US8247536B2Aug 21, 2012
Factor VIII compositions
BOSSARD MARY J8 citations92
US8889831B2Nov 18, 2014
Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypeptide conjugate
BOSSARD MARY J4 citations84
US8143378B2Mar 27, 2012
Polymer factor VIII moiety conjugates
BOSSARD MARY J7 citations84
US8133977B2Mar 13, 2012
Polymer-factor VIII moiety conjugates
BOSSARD MARY J7 citations84
US8618259B2Dec 31, 2013
Polymer-factor VIII conjugate compositions
BOSSARD MARY J1 citations63
US8519102B2Aug 27, 2013
Polymer Factor VIII moiety conjugates
BOSSARD MARY J1 citations63
US9101670B2Aug 11, 2015
Conjugates of an anti-TNF-α antibody
BOSSARD MARY J3 citations61
US8586711B2Nov 19, 2013
Polymer-factor IX moiety conjugates
BOSSARD MARY J1 citations61
US8133865B2Mar 13, 2012
von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage
BOSSARD MARY J1 citations61
US8420068B2Apr 16, 2013
Polymer-based compositions and conjugates of antimicrobial agents
BOSSARD MARY J1 citations60
US8273339B2Sep 25, 2012
Polymer-based compositions and conjugates of antimicrobial agents
BOSSARD MARY J1 citations60
US9539337B2Jan 10, 2017
Compositions comprising two different populations of polymer-active agent conjugates
BOSSARD MARY J0 citations52
US9493544B2Nov 15, 2016
Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkage
BOSSARD MARY J0 citations51
NEKTAR THERAPEUTICS
16 patentsUS8636994B2Jan 28, 2014
Polymer-based compositions and conjugates of antimicrobial agents
NEKTAR THERAPEUTICS49 citations96
US10960079B2Mar 30, 2021
Conjugates of an IL-2 moiety and a polymer
NEKTAR THERAPEUTICS14 citations93
US7863421B2Jan 4, 2011
Polymer-factor VIII moiety conjugates
NEKTAR THERAPEUTICS14 citations93
US7858749B2Dec 28, 2010
Polymer-factor VIII moiety conjugates
NEKTAR THERAPEUTICS14 citations93
US9999657B2Jun 19, 2018
Polymer-factor VIII moiety conjugates
NEKTAR THERAPEUTICS2 citations84
US11141465B2Oct 12, 2021
Method of making a water-soluble polymer-factor VIII moiety conjugate
NEKTAR THERAPEUTICS1 citations73
US9682153B2Jun 20, 2017
Polymer conjugates of therapeutic peptides
NEKTAR THERAPEUTICS3 citations68
US12247059B2Mar 11, 2025
Conjugates of an IL-2 moiety and a polymer
NEKTAR THERAPEUTICS0 citations62
US7714114B2May 11, 2010
Conjugates of an EPO moiety and a polymer
NEKTAR THERAPEUTICS4 citations61
US12324828B2Jun 10, 2025
Conjugates of a factor VIII moiety having an oxime-containing linkage
NEKTAR THERAPEUTICS0 citations59
US11628205B2Apr 18, 2023
Conjugates of a factor VIII moiety having an oxime-containing linkage
NEKTAR THERAPEUTICS0 citations59
US9636412B2May 2, 2017
Conjugates of an anti-TNF-alpha antibody
NEKTAR THERAPEUTICS1 citations58
US8349800B2Jan 8, 2013
Von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage
NEKTAR THERAPEUTICS0 citations51
US9763995B2Sep 19, 2017
Polymer conjugates of protegrin peptides
NEKTAR THERAPEUTICS0 citations50
US10232042B2Mar 19, 2019
Conjugates of an anti-TNF-alpha antibody
NEKTAR THERAPEUTICS0 citations47
US9347054B2May 24, 2016
Polymer factor IX moiety conjugates
NEKTAR THERAPEUTICS0 citations47